We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
UnitedHealth Group (UNH) Falls More Steeply Than Broader Market: What Investors Need to Know
Read MoreHide Full Article
UnitedHealth Group (UNH - Free Report) closed at $334.20 in the latest trading session, marking a -2.02% move from the prior day. The stock's change was less than the S&P 500's daily loss of 0.24%. Elsewhere, the Dow lost 0.62%, while the tech-heavy Nasdaq added 0.23%.
Prior to today's trading, shares of the largest U.S. health insurer had gained 6.42% outpaced the Medical sector's gain of 2.79% and the S&P 500's gain of 1.31%.
The investment community will be closely monitoring the performance of UnitedHealth Group in its forthcoming earnings report. The company is scheduled to release its earnings on January 27, 2026. The company is forecasted to report an EPS of $2.09, showcasing a 69.31% downward movement from the corresponding quarter of the prior year. Meanwhile, our latest consensus estimate is calling for revenue of $113.64 billion, up 12.73% from the prior-year quarter.
For the full year, the Zacks Consensus Estimates project earnings of $16.3 per share and a revenue of $448.05 billion, demonstrating changes of -41.07% and +11.94%, respectively, from the preceding year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for UnitedHealth Group. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has remained unchanged. As of now, UnitedHealth Group holds a Zacks Rank of #3 (Hold).
From a valuation perspective, UnitedHealth Group is currently exchanging hands at a Forward P/E ratio of 20.92. For comparison, its industry has an average Forward P/E of 14.38, which means UnitedHealth Group is trading at a premium to the group.
One should further note that UNH currently holds a PEG ratio of 2.22. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The Medical - HMOs industry currently had an average PEG ratio of 1.35 as of yesterday's close.
The Medical - HMOs industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 189, positioning it in the bottom 24% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
UnitedHealth Group (UNH) Falls More Steeply Than Broader Market: What Investors Need to Know
UnitedHealth Group (UNH - Free Report) closed at $334.20 in the latest trading session, marking a -2.02% move from the prior day. The stock's change was less than the S&P 500's daily loss of 0.24%. Elsewhere, the Dow lost 0.62%, while the tech-heavy Nasdaq added 0.23%.
Prior to today's trading, shares of the largest U.S. health insurer had gained 6.42% outpaced the Medical sector's gain of 2.79% and the S&P 500's gain of 1.31%.
The investment community will be closely monitoring the performance of UnitedHealth Group in its forthcoming earnings report. The company is scheduled to release its earnings on January 27, 2026. The company is forecasted to report an EPS of $2.09, showcasing a 69.31% downward movement from the corresponding quarter of the prior year. Meanwhile, our latest consensus estimate is calling for revenue of $113.64 billion, up 12.73% from the prior-year quarter.
For the full year, the Zacks Consensus Estimates project earnings of $16.3 per share and a revenue of $448.05 billion, demonstrating changes of -41.07% and +11.94%, respectively, from the preceding year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for UnitedHealth Group. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has remained unchanged. As of now, UnitedHealth Group holds a Zacks Rank of #3 (Hold).
From a valuation perspective, UnitedHealth Group is currently exchanging hands at a Forward P/E ratio of 20.92. For comparison, its industry has an average Forward P/E of 14.38, which means UnitedHealth Group is trading at a premium to the group.
One should further note that UNH currently holds a PEG ratio of 2.22. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The Medical - HMOs industry currently had an average PEG ratio of 1.35 as of yesterday's close.
The Medical - HMOs industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 189, positioning it in the bottom 24% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.